The same biochemical outcomes, except for mitochondrial mass (CS activity) and αGP-mediated respiration, correlated with FXTAS severity (i.e., stage; Figure 1) indicating that the morbidity of this neurodegenerative disease is also reflected as a peripheral deficit in bioenergetics. The gene discussed is CS; the disease is fragile X-associated tremor/ataxia syndrome.